申请人:BASF Aktiengesellschaft
公开号:US04428950A1
公开(公告)日:1984-01-31
Novel (hetarylphenoxy)-(phenylpiperazinyl)-propanols of the formula ##STR1## where R.sup.1 is hydrogen, amino or alkyl of 1 to 4 carbon atoms, R.sup.2 is hydrogen, halogen, alkyl of 1 to 4 carbon atoms or alkoxy where alkyl is of 1 to 3 carbon atoms, the phenyl ring can be monosubstituted or disubstituted by R.sup.2, and the heterocyclic structure Het. is pyrimidinyl, triazol-1-yl, imidazol-1-yl, pyrazol-3-yl or isoxazol-3-yl, and their physiologically tolerated addition salts with acids, processes for their preparation, and pharmaceutical formulations which contain these compounds and exhibit predominantly hypotensive, sedative, neuroleptic and broncholytic properties.
新颖的(杂芳基氧基)-(苯基哌嗪基)-丙醇化合物的化学式为##STR1##其中R.sup.1为氢、氨基或1至4个碳原子的烷基,R.sup.2为氢、卤素、1至4个碳原子的烷基或烷氧基,其中烷基为1至3个碳原子,苯环可以被R.sup.2单取代或双取代,杂环结构Het.为嘧啶基、三唑-1-基、咪唑-1-基、吡唑-3-基或异噁唑-3-基,以及它们与酸形成的生理上耐受的加盐物,它们的制备方法,以及含有这些化合物并主要具有降压、镇静、神经阻滞和支气管扩张作用的药物配方。